Soligenix, Inc. (SNGX) stock
SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.25−0.03 (-9.88%)
Close on Nov 18, 2026Market cap $5.50MP/E –Yield –
Soligenix operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Soligenix's operating cash flow for the twelve months ending Jun 30, 2026 was -$9.74M. For fiscal 2025 it was -$10.27M. The highest annual figure on record is $2.64M in fiscal 2012.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.27M | – |
| FY2024 | Dec 31, 2024 | -$8.40M | – |
| FY2023 | Dec 31, 2023 | -$8.60M | – |
| FY2022 | Dec 31, 2022 | -$12.65M | – |
| FY2021 | Dec 31, 2021 | -$11.74M | – |
| FY2020 | Dec 31, 2020 | -$11.45M | – |
| FY2019 | Dec 31, 2019 | -$7.51M | – |
| FY2018 | Dec 31, 2018 | -$7.24M | – |
| FY2017 | Dec 31, 2017 | -$6.51M | – |
| FY2016 | Dec 31, 2016 | -$4.98M | – |
| FY2015 | Dec 31, 2015 | -$5.39M | – |
| FY2014 | Dec 31, 2014 | -$2.47M | – |
| FY2013 | Dec 31, 2013 | -$4.46M | -269.1% |
| FY2012 | Dec 31, 2012 | $2.64M | – |
| FY2011 | Dec 31, 2011 | -$1.95M | – |
| FY2010 | Dec 31, 2010 | -$5.73M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.71M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.36M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.75M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.93M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.74M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.85M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.23M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.91M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.92M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.34M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.83M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.69M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.92M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.17M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.63M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.25M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.53M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.24M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.06M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.04M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.66M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.99M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.12M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.99M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.64M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.70M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.29M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.68M | – |
| Q3 FY2018 | Sep 30, 2018 | -$967.84K | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.14M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.46M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.32M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.21M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.35M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.63M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.43M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.20M | – |
| Q2 FY2016 | Jun 30, 2016 | -$1.71M | – |
| Q1 FY2016 | Mar 31, 2016 | -$637.84K | – |
See a number that looks wrong?